Global Cancer Pain Management Market is predicted to hit over US$ 7.80 Billion by 2030 according to Renub Research. Pain is a common and dreaded symptom experienced by individuals undergoing cancer treatment and long-term cancer survivors. Cancer pain can result from the disease itself, its treatments, or a combination of both and it may be acute or chronic, with some individuals experiencing pain long after treatment has ended.